-
MedcoHealth Solutions Getting Crushed On Lost Contract
Friday, May 27, 2011 - 10:04am | 104Shares of MedcoHealth Solutions Inc. (NYSE: MHS) are down over 10% this morning after the company confirmed it had lost a contract with the U.S. Federal Worker Health-Benefit Contract to CVS Caremark (NYSE: CVS). The contract is worth $3 billion in 2012, almost 5% of the company's revenue. At...
-
Dougherty & Company Maintains Buy on Bio-Reference Laboratories
Friday, May 27, 2011 - 8:49am | 111Dougherty & Company is out with its report today on Bio-Reference Laboratories (NASDAQ: BRLI), maintaining Buy. In a note to clients, Dougherty & Company writes, "Our Buy rating and $31.00 price target on BRLI are based on the assumption that investors will be willing to pay at least 11.0x...
-
Express Scripts Announces Accelerated Share Repurchase Transactions with Morgan Stanley; Purchase Price $1.75B
Friday, May 27, 2011 - 8:38am | 150Express Scripts, Inc. (Nasdaq: ESRX) announced that it has entered into two accelerated share repurchase, or ASR, transactions with Morgan Stanley (NYSE: MS) to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,750 million. Under the terms of the transactions...
-
Upgrades Downgrades, Stocks to Watch May 27
Friday, May 27, 2011 - 8:36am | 304Medco Health (MHS) Drops pre-open after losing $3B Blue Cross Blue Shield contract Last Night: Blue Coat Systems inc. (BCSI) - 4 Downgrades so far Had pretty bad#'s, offered some opportunity in the post market below 20 Briefly last night before retracing up downgraded to Neutral from Outperform at...
-
Benchmark Increases PT on BRLI
Friday, May 27, 2011 - 7:55am | 96According to a recent report from Benchmark, revenue for Bio-Reference Labs (NASDAQ: BRLI) was up over 24% for F2Q11, exceeding the consensus and forecast previously predicted for the company. Due to these earnings, Benchmark is increasing the price target from $25.00 to $29.00. In the report,...
-
Benchmark Raises PT On Bio-Reference Labs To $29
Friday, May 27, 2011 - 6:22am | 28The Benchmark Company has raised the price target on Bio-Reference Labs (NASDAQ: BRLI) from $25 to $29 and maintains its Buy rating.
-
Earnings Scheduled For May 26
Thursday, May 26, 2011 - 12:45am | 491Big Lots Inc (NYSE: BIG) is projected to report its Q1 earnings at $0.69 per share on revenue of $1.23 billion. Fred's Inc (NASDAQ: FRED) is expected to post its Q1 EPS at $0.24 on revenue of $485.05 million. Tiffany & Co (NYSE: TIF) is projected to report its Q1 EPS at $0.57 on revenue of $...
-
PiperJaffray Reports on Athenahealth
Wednesday, May 25, 2011 - 7:41am | 128PiperJaffray commented on Athenahealth (NASDAQ: ATHN) in a report released yesterday. In the report, PiperJaffray was positive in its assessment of the company. PiperJaffray writes, "In our view, upside to the stock will be primarily driven by upward revisions to estimates. This will happen upon...
-
OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment
Tuesday, May 24, 2011 - 9:22am | 247A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative assessment alone. The study is the second published online this...
-
HMS Awarded Third Party Liability Contract by State of Ohio
Tuesday, May 24, 2011 - 9:03am | 64HMS, a wholly owned subsidiary of HMS Holdings Corp. (NASDAQ: HMSY), today announced that it had been awarded a contract by the Ohio Department of Job and Family Services to perform casualty, third party liability recovery, and financial credit balance services. The contract extends through June 30...
-
Morgan Stanley Reports on Medco Health
Tuesday, May 24, 2011 - 8:27am | 163Morgan Stanley commented on Medco Health (NYSE: MHS) in a report released today. In the report, Morgan Stanley was positive in its assessment of the company. Morgan Stanley writes, "E-prescribing adoption to drive gross margin expansion. E-prescribing has reached an inflection point with adoption...
-
Benzinga's Top Upgrades
Tuesday, May 24, 2011 - 8:24am | 137FBR Capital upgraded Gentiva Health Services Inc (NASDAQ: GTIV) from “underperform” to “market perform.” GTIV's shares closed at $23.91 yesterday. GTIV's PEG ratio is 0.60. Analysts at Credit Suisse upgraded Campbell Soup Company (NYSE: CPB) from “underperform” to “neutral.” CPB's shares closed at...
-
Morgan Stanley Reports on Athenahealth
Tuesday, May 24, 2011 - 8:21am | 167Morgan Stanley commented on Athenahealth (NASDAQ: ATHN) in a report released today. In the report, Morgan Stanley was cautious in its assessment of the stock. Morgan Stanley writes, "Management characterized Anodyne as “a year behind” schedule due to the health issues of its CEO, but indicated...
-
Top 4 Small-Cap Stocks In The Specialized Health Services Industry With The Highest Operating Margin
Tuesday, May 24, 2011 - 1:00am | 132Below are the top small-cap specialized health services stocks on the NYSE, the NASDAQ and the AMEX in terms of operating margin. The trailing-twelve-month operating margin at American Shared Hospital Services (AMEX: AMS) is 17.81%. AMS' ROE for the same period is 3.52%. The trailing-twelve-month...
-
Calls Purchased on Athenahealth, Inc. (ATHN)
Monday, May 23, 2011 - 2:04pm | 144Shares of Athenahealth, Inc. (NASDAQ: ATHN) are lower on the session by 1.95%, currently trading at $45.29. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A...